Development and delivery of RNA-targeting CRISPR systems for anti-viral countermeasures.
Conference
·
OSTI ID:1642815
Abstract not provided.
- Research Organization:
- Sandia National Laboratories (SNL-CA), Livermore, CA (United States)
- Sponsoring Organization:
- DARPA SafeGenes
- DOE Contract Number:
- AC04-94AL85000
- OSTI ID:
- 1642815
- Report Number(s):
- SAND2019-12380C; 680338
- Country of Publication:
- United States
- Language:
- English
Similar Records
RNA targeting CRISPR systems for transcriptional gene regulation and anti-viral countermeasure development.
Development and Delivery of Safe CRISPR-based Anti-Viral Countermeasures Targeting Host and Viral Genomes.
NanoCRISPR Grand Challenge LDRD ? Targeted Delivery of Medical Countermeasures.
Conference
·
Fri Nov 01 00:00:00 EDT 2019
·
OSTI ID:1643300
Development and Delivery of Safe CRISPR-based Anti-Viral Countermeasures Targeting Host and Viral Genomes.
Conference
·
Sun Jul 01 00:00:00 EDT 2018
·
OSTI ID:1806799
NanoCRISPR Grand Challenge LDRD ? Targeted Delivery of Medical Countermeasures.
Conference
·
Mon Aug 01 00:00:00 EDT 2016
·
OSTI ID:1529805